Marrone Bio Innovations, Inc. NASDAQ:MBII

Founder-led company

Marrone Bio Innovations stock price today

$0.798
Financial Health
0
1
2
3
4
5
6
7
8
9

Marrone Bio Innovations stock price monthly change

-17.52%
month

Marrone Bio Innovations stock price quarterly change

-12.38%
quarter

Marrone Bio Innovations stock price yearly change

-45.34%
year

Marrone Bio Innovations key metrics

Market Cap
N/A
Enterprise value
171.55M
P/E
-6.82
EV/Sales
3.86
EV/EBITDA
-11.83
Price/Sales
3.27
Price/Book
6.35
PEG ratio
N/A
EPS
-0.11
Revenue
44.36M
EBITDA
-14.49M
Income
-20.88M
Revenue Q/Q
0.53%
Revenue Y/Y
38.03%
Profit margin
-47.08%
Oper. margin
-43.72%
Gross margin
59.69%
EBIT margin
-43.72%
EBITDA margin
-32.67%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Marrone Bio Innovations stock price history

Marrone Bio Innovations stock forecast

Marrone Bio Innovations financial statements

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Profit margin
Jun 2021 12.59M -3.03M -24.09%
Sep 2021 9.85M -4.94M -50.17%
Dec 2021 10.81M -5.31M -49.11%
Mar 2022 11.09M -7.59M -68.45%
Marrone Bio Innovations, Inc. (NASDAQ:MBII): Earnings per share (EPS)
2021-11-10 -0.03 -0.03
2022-03-28 -0.03 -0.03
2022-05-11 -0.02 -0.04
Marrone Bio Innovations, Inc. (NASDAQ:MBII): Debt to assets
Jun 2021 85618000 50.93M 59.49%
Sep 2021 82138000 51.51M 62.71%
Dec 2021 87056000 57.40M 65.94%
Mar 2022 76214000 53.34M 69.99%
Marrone Bio Innovations, Inc. (NASDAQ:MBII): Cash Flow
Jun 2021 -1.24M -425K 213K
Sep 2021 -308K -361K -1.75M
Dec 2021 -3.39M -188K 8.15M
Mar 2022 -8.39M -198K -1.66M

Marrone Bio Innovations alternative data

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Employee count
Aug 2023 153
Sep 2023 153
Oct 2023 153
Nov 2023 153
Dec 2023 153
Jan 2024 153
Feb 2024 153
Mar 2024 153
Apr 2024 153
May 2024 153
Jun 2024 153
Jul 2024 153

Marrone Bio Innovations other data

Marrone Bio Innovations, Inc. (NASDAQ:MBII): Insider trades (number of shares)
Period Buy Sel
Jul 2021 0 34865
Aug 2021 0 42368
Mar 2022 0 22728
May 2022 0 21009
Jun 2022 0 20492
Transaction Date Insider Security Shares Price per share Total value Source
Option
PITTS KEITH officer: SVP & Chief Sust. Offi..
Restricted Stock Units 102,950 N/A N/A
Option
MOORE LINDA V officer: Chief Legal Officer
Restricted Stock Units 316,153 N/A N/A
Option
MAGO YOGESH director
Restricted Stock Units 321,770 N/A N/A
Option
MARRONE PAMELA G director Restricted Stock Units 195,007 N/A N/A
Option
WOODS ROBERT A director
Restricted Stock Units 455,027 N/A N/A
Option
LEE LARA L director
Restricted Stock Units 167,812 N/A N/A
Option
VASAVADA AMIT officer: SVP & CTO
Restricted Stock Units 129,184 N/A N/A
Option
JOHNSON TIMOTHY B officer: VP (Field and Technical)
Restricted Stock Units 102,167 N/A N/A
Option
MCGOVERN KEITH director
Restricted Stock Units 273,643 N/A N/A
Option
WOCHOK ZACHARY S. director
Restricted Stock Units 429,081 N/A N/A
Patent
Application
Filling date: 12 Mar 2020 Issue date: 11 Aug 2022
Grant
Filling date: 30 Mar 2020 Issue date: 12 Jul 2022
Grant
Filling date: 24 Jun 2019 Issue date: 12 Jul 2022
Application
Filling date: 23 Nov 2021 Issue date: 16 Jun 2022
Application
Filling date: 22 Nov 2021 Issue date: 17 Mar 2022
Application
Filling date: 29 Oct 2019 Issue date: 17 Feb 2022
Application
Filling date: 12 Oct 2021 Issue date: 27 Jan 2022
Grant
Filling date: 6 Sep 2018 Issue date: 28 Dec 2021
Application
Filling date: 23 Aug 2021 Issue date: 23 Dec 2021
Application
Filling date: 23 Aug 2021 Issue date: 16 Dec 2021
Tuesday, 12 July 2022
businesswire.com
Monday, 11 July 2022
globenewswire.com
Tuesday, 17 May 2022
Zacks Investment Research
Wednesday, 11 May 2022
Seeking Alpha
Zacks Investment Research
Monday, 28 March 2022
Zacks Investment Research
Seeking Alpha
Tuesday, 22 March 2022
PennyStocks
Thursday, 17 March 2022
InvestorPlace
Tuesday, 8 March 2022
GlobeNewsWire
Monday, 10 January 2022
Zacks Investment Research
Thursday, 25 November 2021
Seeking Alpha
Tuesday, 16 November 2021
InvestorPlace
Monday, 15 November 2021
Zacks Investment Research
Wednesday, 10 November 2021
Seeking Alpha
Zacks Investment Research
Thursday, 9 September 2021
GlobeNewsWire
Thursday, 19 August 2021
Zacks Investment Research
Wednesday, 18 August 2021
Zacks Investment Research
Monday, 16 August 2021
Seeking Alpha
Zacks Investment Research
Benzinga
GlobeNewsWire
  • What's the price of Marrone Bio Innovations stock today?

    One share of Marrone Bio Innovations stock can currently be purchased for approximately $0.8.

  • When is Marrone Bio Innovations's next earnings date?

    Unfortunately, Marrone Bio Innovations's (MBII) next earnings date is currently unknown.

  • Does Marrone Bio Innovations pay dividends?

    No, Marrone Bio Innovations does not pay dividends.

  • What is Marrone Bio Innovations's stock symbol?

    Marrone Bio Innovations, Inc. is traded on the NASDAQ under the ticker symbol "MBII".

  • What is Marrone Bio Innovations's primary industry?

    Company operates in the Basic Materials sector and Agricultural Inputs industry.

  • How do i buy shares of Marrone Bio Innovations?

    Shares of Marrone Bio Innovations can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Marrone Bio Innovations's key executives?

    Marrone Bio Innovations's management team includes the following people:

    • Mr. Kevin R. Helash Chief Executive Officer & Director(age: 60, pay: $418,620)
    • Dr. Pamela G. Marrone Ph.D. Founder, Advisor & Non-Employee Director(age: 68, pay: $408,630)
  • Is Marrone Bio Innovations founder-led company?

    Yes, Marrone Bio Innovations is a company led by its founder Dr. Pamela G. Marrone Ph.D..

  • How many employees does Marrone Bio Innovations have?

    As Jul 2024, Marrone Bio Innovations employs 153 workers.

  • When Marrone Bio Innovations went public?

    Marrone Bio Innovations, Inc. is publicly traded company for more then 12 years since IPO on 2 Aug 2013.

  • What is Marrone Bio Innovations's official website?

    The official website for Marrone Bio Innovations is marronebio.com.

  • Where are Marrone Bio Innovations's headquarters?

    Marrone Bio Innovations is headquartered at 1540 Drew Ave, Davis, CALIFORNIA.

  • How can i contact Marrone Bio Innovations?

    Marrone Bio Innovations's mailing address is 1540 Drew Ave, Davis, CALIFORNIA and company can be reached via phone at +1 530 750 2800.

Marrone Bio Innovations company profile:

Marrone Bio Innovations, Inc.

marronebio.com
Exchange:

NASDAQ

Full time employees:

153

Industry:

Agricultural Inputs

Sector:

Basic Materials

Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide that controls chewing and sucking insects and mites; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. It provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc. was incorporated in 2006 and is headquartered in Raleigh, North Carolina.

1540 Drew Ave
Davis, CALIFORNIA 27617

CIK: 0001441693
ISIN: US57165B1061
CUSIP: 57165B106